Speech-Language Pathologists in Winchester, IL Accepting Medicare
4 Speech-Language Pathologists found. Showing 1 - 4
 Elizabeth Ann Grogan Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 121 N Main St, Winchester, IL 62694 Phone: 217-370-5953 |
Nicole Dorsey, M.S. CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 111 S Mechanic St, Winchester, IL 62694 Phone: 217-473-7922 |
Mrs. Jill Bergstrom Cox, MS-CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 434 N Main St, Winchester, IL 62694 Phone: 217-742-9569 |
Mrs. Jamie Lynn Mcdade-daws, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 540 Winchester Glasgow Rd, Winchester, IL 62694 Phone: 217-473-9067 |
News Archive
Study sheds light on pancreatic cancer development and new potential drug targets
Researchers at the Moores Cancer Center at the University of California, San Diego, have found one reason that pancreatic cancer tumors are so difficult to treat with drugs. They have shown how a molecular switch steps up pancreatic cancer cell survival as well as resistance to a standard chemotherapy drug, and have identified alternate routes cancer cells take to avoid the effects of the therapy.
Eclipsys' PeakPractice EMR solution receives NEyePA's preferred provider endorsement
Eclipsys Corporation, The Outcomes Company®, today announced that Eclipsys' PeakPractice™ electronic medical record (EMR) solution recently received preferred provider endorsement by the National EyePA Coalition (NEyePA), a large independent physician association (IPA) representing 4,900 optometrists and ophthalmologists in 28 IPAs in 26 states.
Faster method for detecting disease-causing mutations developed by Pitt researchers
University of Pittsburgh researcher Alexander Star and colleagues at a California-based company, Nanomix, Inc., have developed devices made of carbon nanotubes that can find mutations in genes causing hereditary diseases, they report in the Jan. 16 issue of the journal Proceedings of the National Academy of Science.
Study shows Diovan reduced urinary protein excretion in patients with type 2 diabetes and high blood pressure
In patients with high blood pressure and type 2 diabetes, the blood pressure-lowering medication Diovan (valsartan) significantly reduced urinary protein excretion, with high doses providing the greatest sustained reduction , according to data presented at the Amer ican Heart Association's (AHA) Annual Scientific Sessions.
› Verified 9 days ago
Speech-Language Pathologists
Chiropractors
Occupational Therapists